About Hypoparathyroidism

Overview
Hypoparathyroidism is a rare endocrine disorder in which the body has too little parathyroid hormone (PTH), the hormone that helps regulate calcium and phosphorus levels. Low or inappropriately normal PTH can lead to low calcium levels and high phosphorus levels in the blood. The most common cause is damage to or removal of the parathyroid glands during thyroid, parathyroid, or other neck surgery, but hypoparathyroidism can also be caused by autoimmune disease, inherited conditions, severe or prolonged low magnesium levels, radiation to the head or neck, or inflammatory disorders. Symptoms can range from tingling in the lips, fingers, or toes and muscle cramps to seizures, abnormal heart rhythms, or breathing problems in severe cases. Treatment usually includes calcium and active vitamin D, with regular blood and urine monitoring; some adults may be treated with a PTH replacement medicine. A healthcare professional can diagnose the condition and tailor treatment to help prevent both low-calcium symptoms and complications from overtreatment.
Causes and Risk Factors

The main causes of hypoparathyroidism include:

  • Neck surgery: The most common cause is accidental damage to, removal of, or reduced blood supply to the parathyroid glands during thyroid, parathyroid, or other neck surgery.
  • Autoimmune disease: The immune system may attack the parathyroid glands, sometimes as part of autoimmune polyglandular syndrome.
  • Genetic or developmental conditions: Some people are born with absent, underdeveloped, or poorly functioning parathyroid glands, or with genetic changes that affect calcium sensing or PTH production.
  • Low magnesium levels: Severe or prolonged low magnesium can reduce PTH release or make the body less responsive to PTH, which can cause low calcium levels.
  • Radiation, cancer, or inflammatory disease: Radiation to the head or neck, cancer involving nearby tissues, or inflammatory conditions such as sarcoidosis or amyloidosis can rarely impair parathyroid function.

Risk factors of hypoparathyroidism include:

  • Genetic changes, such as mutations in the CASR gene or autoimmune regulator gene (AIRE)
  • Trauma to the neck, such as from an injury during a car wreck or fall
  • Diseases present at birth that affect the development and function of the parathyroid glands
  • Inherited or developmental conditions that affect formation or function of the parathyroid glands
  • Extensive radiation therapy to treat head and neck cancer

It is important to note that certain surgical procedures, such as total thyroidectomy (removal of the thyroid gland) with neck clearance (removal of lymph nodes and nearby tissues), have been associated with an increased risk of developing hypoparathyroidism.

Please consult with your healthcare professional for more information about risk factors and individualized recommendations.

Symptoms

The most common early symptoms of hypoparathyroidism include:

  • Tingling sensation in the fingers, toes, and lips
  • Muscle cramps
  • Fatigue
  • Brittle fingernails and hair
  • Dry skin

Low calcium can also cause numbness, anxiety or irritability, trouble concentrating, memory problems, abdominal cramps, or painful spasms of the hands, feet, throat, or face.

As hypoparathyroidism progresses or becomes more severe, additional symptoms may occur, such as:

  • Headaches
  • Severe mood changes
  • Twitching facial muscles

Symptoms can vary from person to person. Seek urgent medical care for seizures, fainting, severe muscle spasms, difficulty breathing or swallowing, chest pain, or an irregular heartbeat. If you suspect hypoparathyroidism or have ongoing symptoms of low calcium, consult a healthcare professional for diagnosis and treatment.

Diagnosis

Hypoparathyroidism is usually diagnosed with blood tests showing low calcium together with low or inappropriately normal PTH; repeat testing is often used to confirm the diagnosis. Healthcare professionals may use the following evaluations:

  • Physical exam: The healthcare provider will do a complete physical exam, which includes a neurological exam. They will look for signs like muscle cramps, tingling in the fingers or around the mouth, and unusual muscle twitches, which can indicate low calcium levels.
  • Lab tests: Blood tests typically check calcium, phosphorus, magnesium, kidney function, vitamin D, and PTH levels. Results that support hypoparathyroidism include low calcium, high phosphorus, and low or inappropriately normal PTH.

Additional tests: To rule out other potential causes and assess complications, healthcare providers may perform the following tests:

  • Nerve function tests: These measure electrical activity in muscles and nerves.
  • Urine calcium testing: A 24-hour urine collection or other urine test may be used to measure calcium loss in the urine and help reduce the risk of kidney stones or kidney damage during treatment.
  • Electrocardiogram (ECG): It assesses a person's heart health.
  • Additional blood tests: These may check magnesium, 25-hydroxyvitamin D, kidney function, and other values that can affect calcium levels or treatment decisions.

To determine the severity of hypoparathyroidism, specific additional examinations, tests, and procedures may be recommended based on the gathered information and results of the initial evaluation. These can vary depending on the individual's symptoms and body system being evaluated. It is essential to follow up with your healthcare provider if any symptoms worsen or change after the initial evaluation.

Remember, only your healthcare provider can determine the appropriate examinations, tests, and procedures for your specific situation.

Treatment Options

Treatment for hypoparathyroidism is individualized. The main goals are to relieve symptoms of low calcium, keep blood calcium in a safe target range, lower high phosphorus when possible, avoid too much calcium in the blood or urine, and protect the kidneys and other organs from calcium deposits.

Treatment options may include:

  • Calcium and active vitamin D: First-line treatment usually includes oral calcium supplements and active vitamin D, such as calcitriol, to raise calcium into a target range while avoiding overtreatment. Magnesium may be replaced if levels are low.
  • PTH replacement therapy: Palopegteriparatide (Yorvipath) is a parathyroid hormone analog approved for adults with hypoparathyroidism. It may be considered when conventional therapy is not adequate or is difficult to manage. It is not for acute postsurgical hypoparathyroidism and requires individualized dosing and monitoring because both low and high calcium levels can occur.

Experimental PTH-based therapies: Eneboparatide (AZP-3601) is an investigational PTH receptor 1 agonist being studied for adults with chronic hypoparathyroidism. It has shown positive Phase 3 trial results, but it should not be described as an approved standard treatment unless approved by health authorities.

  • Emergency treatment: Severe low calcium can be a medical emergency. People with seizures, severe muscle spasms, abnormal heart rhythms, or breathing problems may need urgent treatment with intravenous calcium and close monitoring.
  • Self-care and follow-up: Taking medicines as prescribed, keeping follow-up appointments, and reporting new or worsening symptoms can help maintain the right balance of calcium and phosphorus and reduce the risk of long-term complications.

Remember, these are general recommendations. The specific treatment plan should be discussed with a healthcare professional.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.